Inhibition of early steps in the lentiviral replication cycle by cathelicidin host defense peptides
about
Vitamin D and the anti-viral stateAntiviral potential of cathelicidinsHigh-quality 3D structures shine light on antibacterial, anti-biofilm and antiviral activities of human cathelicidin LL-37 and its fragments.Mechanisms and modifications of naturally occurring host defense peptides for anti-HIV microbicide developmentAntiviral activity and increased host defense against influenza infection elicited by the human cathelicidin LL-37New approaches to making the microenvironment of the female reproductive tract hostile to HIV.Efficient generation of double heterologous promoter controlled oncolytic adenovirus vectors by a single homologous recombination step in Escherichia coliAnti-HIV activity in cervical-vaginal secretions from HIV-positive and -negative women correlate with innate antimicrobial levels and IgG antibodiesA comparative proteomic analysis of the soluble immune factor environment of rectal and oral mucosa.Trappin-2/elafin modulate innate immune responses of human endometrial epithelial cells to PolyI:CHost defense peptides as effector molecules of the innate immune response: a sledgehammer for drug resistance?Human defensins 5 and 6 enhance HIV-1 infectivity through promoting HIV attachment.Anti-HIV-1 activity of elafin is more potent than its precursor's, trappin-2, in genital epithelial cellsNatural antimicrobial peptides as promising anti-HIV candidates.Peptide antimicrobial agents.Vitamin D signaling, infectious diseases, and regulation of innate immunity.Vitamin D in HIV-Infected Patients.Host defense peptides in wound healing.Vitamin D induces innate antibacterial responses in human trophoblasts via an intracrine pathwayInnate Immunity in the Female Reproductive Tract: Role of Sex Hormones in Regulating Uterine Epithelial Cell Protection Against Pathogens.Vitamin D3: a helpful immuno-modulator.War and peace between WAP and HIV: role of SLPI, trappin-2, elafin and ps20 in susceptibility to HIV infection.Recent advances targeting innate immunity-mediated therapies against HIV-1 infection.Current scenario of peptide-based drugs: the key roles of cationic antitumor and antiviral peptides.Anti-human immunodeficiency virus type 1 activities of antimicrobial peptides derived from human and bovine cathelicidinsUnique features of human cathelicidin LL-37.Protegrin-1 inhibits dengue NS2B-NS3 serine protease and viral replication in MK2 cells.Bioengineered human skin: working the bugs out.Vitamin D insufficiency and deficiency among HIV-1-infected patients in a tropical setting.Cathelicidins display conserved direct antiviral activity towards rhinovirus.The therapeutic impact of HNP-1 in condyloma acuminatum.Enhanced resistance to bacterial infection in protegrin-1 transgenic mice.Highly efficient inhibition of human immunodeficiency virus type 1 reverse transcriptase by aptamers functionalized gold nanoparticles.Molecular characterization of the Tax-containing HTLV-1 enhancer complex reveals a prominent role for CREB phosphorylation in Tax transactivation.
P2860
Q24613615-565E0205-7667-435D-8134-8A84D10DAA61Q27006576-33BE4DA4-D9C5-459B-A433-D4B05DB8002AQ27692605-AF233290-9974-464D-A4D5-4440DB4FABCEQ28257799-B1DDBDD0-8018-4456-97C4-BB05A68C5B60Q28477585-2DC5EDF9-B3F5-4EFD-A73B-E1F41D73B2D6Q30398454-7F701CF3-671B-451D-9BCF-D7259E79689DQ33252754-3606EEB2-93DF-4C98-9647-EFD85EA184A0Q33627673-4FD0D57D-52D8-4DA8-ABC0-65C153B7A459Q33825756-FF999AB4-E93A-4D4A-A9CB-A87CC910054DQ34251265-9714C1F4-AC07-4037-9AB3-D55FF1258316Q35010044-F15637B2-ECF9-461D-9A42-3238B9B7A7DBQ35136126-4A304D97-C18D-48E5-B67B-DDE425AED4C8Q35868058-BB44BFE8-590A-4066-AB0E-70A6B0A11C9BQ36514316-B756976C-E001-4CED-A211-D16BC552BECCQ36538861-369C40DB-22C3-4399-B5F2-6249DA560D88Q36845164-54086182-FD34-4D82-98D5-E830DBD82804Q36884537-81267225-3A43-43C6-9EDF-2AE4F4B95977Q37127271-5B18CB79-FC7B-4D6B-A85B-2ADD5D73A0FBQ37245956-97E3EB15-28D8-4B4F-813A-9F65AD3B416BQ37280601-160A9238-604F-474B-94C2-C3F9D5FC4B42Q37927252-8CE2C088-F041-4B90-83E8-F738842436F1Q37936538-83F78DEC-BD06-41CA-9B5A-A173270D577FQ38035344-733DBDE4-C331-4C8A-A5CA-E2561B09C065Q38160482-AB7E1E8A-3829-4A80-AA4F-6E134F901FD6Q38551785-B9A19361-0015-4CC1-85E8-C48D9B88DD9DQ38598753-CACD0E60-FE45-4BC5-B7F9-338C8195EFBEQ39254220-B80A0F68-5EA2-43EC-AADE-0FDA2C6CCA44Q39505016-C3C587D5-B96E-44FE-8AB9-3C77DAD5FCF6Q39591171-FF605D7B-B7C5-4142-BDE0-8F5B5EB5996AQ40099023-68DC3F83-8B42-4A21-B4C1-D79DBA0DEB2FQ42174602-94E96B46-ADC8-4018-950A-81CABCF9D95EQ43089989-2A5DCB84-5687-4DC5-B3DF-7973B128B426Q44142656-02C815AE-3DB0-4A6F-91AA-71B47D367DA4Q55239404-7CFFFF53-19B7-40C9-8CD0-D0F7160F5D11
P2860
Inhibition of early steps in the lentiviral replication cycle by cathelicidin host defense peptides
description
2005 nî lūn-bûn
@nan
2005 թուականին հրատարակուած գիտական յօդուած
@hyw
2005 թվականին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Inhibition of early steps in t ...... elicidin host defense peptides
@ast
Inhibition of early steps in t ...... elicidin host defense peptides
@en
Inhibition of early steps in t ...... elicidin host defense peptides
@nl
type
label
Inhibition of early steps in t ...... elicidin host defense peptides
@ast
Inhibition of early steps in t ...... elicidin host defense peptides
@en
Inhibition of early steps in t ...... elicidin host defense peptides
@nl
prefLabel
Inhibition of early steps in t ...... elicidin host defense peptides
@ast
Inhibition of early steps in t ...... elicidin host defense peptides
@en
Inhibition of early steps in t ...... elicidin host defense peptides
@nl
P2093
P2860
P356
P1433
P1476
Inhibition of early steps in t ...... elicidin host defense peptides
@en
P2093
Bettina Tippler
Evert Lamme
Hans-Ulrich Steinau
Heinz-Herbert Homann
Janine Mertens
Lars Steinstraesser
Marcus Lehnhardt
Oliver Wildner
P2860
P2888
P356
10.1186/1742-4690-2-2
P407
P50
P577
2005-01-01T00:00:00Z
P5875
P6179
1019993308